SCHEMBL3419650

SCHEMBL3419650

CC=CCCCCCC=CCCC(C)C

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 1/20 0.37
HIF1A Q16665 2/20 0.36
EPAS1 Q99814 2/20 0.36
TRPV1 Q8NER1 2/20 0.34
TRPM8 Q7Z2W7 1/20 0.34
TERT O14746 3/20 0.33
MAPT P10636 2/20 0.33
BLM P54132 2/20 0.33
HSD17B10 Q99714 2/20 0.33
FABP4 P15090 2/20 0.33
F7 P08709 2/20 0.33
F3 P13726 2/20 0.33
FAAH O00519 2/20 0.33
PTPN1 P18031 2/20 0.33
PPARG P37231 2/20 0.33
PPARD Q03181 2/20 0.33
PPARA Q07869 2/20 0.33
GMNN O75496 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5597029 1.00 CNR1 (0.37) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL2008820 0.88 LMNA (0.42) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL3432184 0.88 CNR1 (0.38) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL2007794 0.88 LMNA (0.42) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL2008818 0.88 LMNA (0.42) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL5597055 0.88 CNR1 (0.38) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL28176224 0.88 LMNA (0.42) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL2007796 0.88 LMNA (0.42) CNR1HIF1AEPAS1TRPV1TRPM8
SCHEMBL56968 0.87
SCHEMBL56967 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022059684-A1 VITAMIN D DERIVATIVE HAVING CYCLIC AMINE IN SIDE CHAIN 帝人ファーマ株式会社 2022-03-24 WO claimed
EP-0980203-B1 ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES SQUIRES MERYL (US) 2007-04-04 EP claimed
US-20260041100-A1 STABLE LIQUID FORMULATIONS FOR NITROGEN-FIXING MICROORGANISMS PIVOT BIO INC (US) 2026-02-12 US disclosed
US-20260020560-A1 AGRICULTURAL METHYL DIHYDROJASMONATE COMPOSITIONS IMPELLO BIOSCIENCES INC (US) 2026-01-22 US disclosed
US-12478068-B2 Stable liquid formulations for nitrogen-fixing microorganisms PIVOT BIO, INC. (US) 2025-11-25 US disclosed
US-20250145544-A1 DRY FORMULATED NITROGEN-FIXING MICROBE PACKAGED IN WATER-SOLUBLE FILM FOR RAPID AND SAFE DISPERSAL IN AQUEOUS MIXTURES PIVOT BIO, INC. (US) 2025-05-08 US disclosed
US-20250089708-A1 BOTANICAL DISINFECTING, CLEANING, AND DEODORIZING FORMULATION AND METHOD OF USE BOND JERRY R (US) 2025-03-20 US disclosed
US-20230292747-A1 Composition for use in agriculture BAYER AKTIENGESELLSCHAFT (DE) 2023-09-21 US disclosed
US-11612885-B2 Methods, compositions and kits useful for pH gradient cation exchange chromatography WATERS TECHNOLOGIES CORPORATION 2023-03-28 US disclosed
WO-2022230954-A1 METHOD FOR PRODUCING OLIGONUCLEIC ACID COMPOUND 日本新薬株式会社 2022-11-03 WO disclosed
US-20220307193-A1 FLUORINE-FREE FIBROUS TREATING COMPOSITIONS, TREATED SUBSTRATES, AND TREATING METHODS 3M INNOVATIVE PROPERTIES CO (US) 2022-09-29 US disclosed
US-11377785-B2 Fluorine-free fibrous treating compositions, treated substrates, and treating methods 3M INNOVATIVE PROPERTIES COMPANY (US) 2022-07-05 US disclosed
US-20220202020-A1 ALL PURPOSE CLEANER, DISINFECTANT, DUST SUPPRESSANT, BIOAEROSOL PARTICLE REMOVER, AND PESTICIDE MICROEMULSION FORMULATION AND METHOD OF USE BOND JERRY R (US) 2022-06-30 US disclosed
US-11284624-B2 Method of suppressing dust and removing bioaerosol particles using microemulsion formulation BOND JERRY R (US) 2022-03-29 US disclosed
US-20170258861-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis SQUIRES MERYL J (US) 2017-09-14 US disclosed
EP-3184206-A1 DISPERSIONS OF METALS AND/OR METAL COMPOUNDS Solvay SA (BE) 2017-06-28 EP disclosed
US-9662360-B2 Treatment of herpes, pseudomonas, staph, and hepatitis MERITUS CORPORATION (DM) 2017-05-30 US disclosed
US-20160151436-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis MERITUS CORPORATION (DM) 2016-06-02 US disclosed
US-20100303935-A1 Medicinal Composition MCGINLEY PARTNERS, LLC (US) 2010-12-02 US disclosed
US-20090191288-A1 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases SQUIRES MERYL J 2009-07-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260020560-A1 AGRICULTURAL METHYL DIHYDROJASMONATE COMPOSITIONS DGKA, DGKG, DGKB CNR1 32/4885HIF1A 2810/4885EPAS1 2861/4885
US-20160151436-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis NISCH, CUTA, HRH1 CNR1 1641/4885HIF1A 672/4885EPAS1 2519/4885
US-20170258861-A1 Treatment of Herpes, Pseudomonas, Staph, and Hepatitis NISCH, CUTA, HRH1 CNR1 1641/4885HIF1A 672/4885EPAS1 2519/4885
US-20090191288-A1 Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases ASPH, KCNH3, PRPH CNR1 1644/4885HIF1A 803/4885EPAS1 2927/4885
US-20100303935-A1 Medicinal Composition MUSK, TNNC1, ACHE CNR1 189/4885HIF1A 2646/4885EPAS1 2988/4885
US-20260041100-A1 STABLE LIQUID FORMULATIONS FOR NITROGEN-FIXING MICROORGANISMS PGLS, NANS, PTMS CNR1 3534/4885HIF1A 2163/4885EPAS1 3158/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.